ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TMBR Company Profile and Key Details

AMEX : TMBR

Timber Pharmaceuticals, Inc.

$0.34

0.0025+0.74%

At Close 4:00 PM

Not Actively Trading

75.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

TMBR Stock Price Chart

Stock Price Today

Timber Pharmaceuticals, Inc. (TMBR) stock surged +0.74%, trading at $0.34 on AMEX, up from the previous close of $0.34. The stock opened at $0.34, fluctuating between $0.32 and $0.35 in the recent session.

Stock Snapshot

0.3401

Prev. Close

0.34

Open

1.18M

Market Cap

3.43M

Number of Shares

0.3202

Day Low

0.35

Day High

-0.17390862944162436

P/E Ratio

81.17%

Free Float in %

-1.97

EPS (TTM)

-0.85

Book Value

-4.51

Cash Flow per Share

130.46K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 26, 2023	0.00	0.01	0.00	0.01	12.58K
Dec 22, 2023	0.00	0.00	0.00	0.00	8.76K
Dec 21, 2023	0.00	0.05	0.00	0.05	1.54K
Dec 20, 2023	0.00	0.00	0.00	0.00	2.08K
Dec 19, 2023	0.00	0.00	0.00	0.00	3.04K
Dec 18, 2023	0.00	0.01	0.00	0.01	2.78K
Dec 15, 2023	0.00	0.02	0.00	0.02	3.24K
Dec 14, 2023	0.10	0.10	0.00	0.02	24.6K
Dec 13, 2023	0.00	0.03	0.00	0.03	1.02K
Dec 12, 2023	0.01	0.04	0.01	0.01	2.23K
Dec 11, 2023	0.04	0.04	0.02	0.03	1.69K
Dec 08, 2023	0.02	0.04	0.00	0.04	12.65K
Dec 07, 2023	0.02	0.05	0.02	0.05	13.61K
Dec 06, 2023	0.02	0.30	0.01	0.30	30.35K
Dec 05, 2023	0.01	0.03	0.01	0.02	11.41K
Dec 04, 2023	0.00	0.03	0.00	0.02	42.45K
Nov 28, 2023	0.34	0.35	0.32	0.34	130.46K
Nov 27, 2023	0.36	0.37	0.33	0.34	265.34K
Nov 24, 2023	0.38	0.39	0.35	0.37	206.27K
Nov 22, 2023	0.48	0.48	0.36	0.36	848.04K

Contact Details

Basking Ridge, NJ 07920

United States

Website: https://www.timberpharma.comContact: 973 314 9577

About Company

Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in the development of TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist that is in preclinical development for the treatment of sclerotic skin diseases. In addition, the company engages in the development of BPX-01, which is in Phase 3 topical minocycline for the treatment of inflammatory lesions of acne vulgaris; and BPX-04 that is a Phase 3 ready topical minocycline for the treatment of papulopustular rosacea. It has license agreement with AFT Pharmaceuticals Limited. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey.

Frequently Asked Questions

What is the current Timber Pharmaceuticals, Inc. (TMBR) stock price?

Timber Pharmaceuticals, Inc. (AMEX: TMBR) stock price is $0.34 in the last trading session. During the trading session, TMBR stock reached the peak price of $0.35 while $0.32 was the lowest point it dropped to. The percentage change in TMBR stock occurred in the recent session was 0.74% while the dollar amount for the price change in TMBR stock was $0.00.

TMBR's industry and sector of operation?

The AMEX listed TMBR is part of Biotechnology industry that operates in the broader Healthcare sector. Timber Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TMBR?

Mr. John Koconis M.B.A.
Chairman, Chief Executive Officer & Pres
Dr. Alan Mendelsohn M.D.
Executive Vice President & Chief Medical Officer
Mr. Joseph Lucchese
Executive Vice President, Chief Financial Officer, Treasurer & Sec.

How TMBR did perform over past 52-week?

TMBR's closing price is 7.06% higher than its 52-week low of $0.32 where as its distance from 52-week high of $3.39 is -89.89%.

How many employees does TMBR have?

Number of TMBR employees currently stands at 9.

Link for TMBR official website?

Official Website of TMBR is: https://www.timberpharma.com

How do I contact TMBR?

TMBR could be contacted at phone 973 314 9577 and can also be accessed through its website. TMBR operates from 110 Allen Road, Basking Ridge, NJ 07920, United States.

How many shares of TMBR are traded daily?

TMBR stock volume for the day was 130.46K shares. The average number of TMBR shares traded daily for last 3 months was 107.9K.

What is the market cap of TMBR currently?

The market value of TMBR currently stands at $1.18M with its latest stock price at $0.34 and 3.43M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	9
Beta	-0.65
Sales or Revenue	$83.18K
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology